DAVIDSON KEMPNER CAPITAL MANAGEMENT LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 12 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,264,731
-9.2%
25,000,0000.0%0.24%
-31.2%
Q2 2023$16,812,500
-12.7%
25,000,0000.0%0.35%
+7.6%
Q1 2023$19,256,425
+102072.4%
25,000,0000.0%0.33%
+16250.0%
Q4 2022$18,847
-99.9%
25,000,0000.0%0.00%
-99.5%
Q3 2022$19,953,000
+10.0%
25,000,0000.0%0.37%
+16.6%
Q2 2022$18,139,000
-13.3%
25,000,0000.0%0.31%
+16.7%
Q1 2022$20,932,000
+3.7%
25,000,0000.0%0.27%
-9.4%
Q4 2021$20,188,000
+17.4%
25,000,000
+8.7%
0.30%
+20.7%
Q3 2021$17,194,000
-13.9%
23,000,000
+15.0%
0.25%
+58.7%
Q2 2021$19,960,000
-2.3%
20,000,0000.0%0.16%
-23.6%
Q1 2021$20,429,000
-17.9%
20,000,0000.0%0.20%
-30.5%
Q4 2020$24,888,000
+49.9%
20,000,000
+42.9%
0.29%
+23.7%
Q3 2020$16,600,000
-15.1%
14,000,0000.0%0.24%
-50.0%
Q2 2020$19,551,000
-1.5%
14,000,0000.0%0.47%
-10.9%
Q1 2020$19,853,000
-0.4%
14,000,0000.0%0.53%
+18.0%
Q4 2019$19,941,00014,000,0000.45%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birch Grove Capital LP 8,000,000$5,215,0009.09%
BRAIDWELL LP 65,976,000$40,943,9961.29%
Context Capital Management, LLC 21,494$13,3291.07%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 30,500,000$20,663,7500.86%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 25,000,000$15,264,7310.24%
DeepCurrents Investment Group LLC 4,250,000$2,700,9940.12%
CAPSTONE INVESTMENT ADVISORS, LLC 7,500,000$4,654,4190.02%
Verition Fund Management LLC 1,359$843,3810.01%
LAZARD ASSET MANAGEMENT LLC 6,500,000$4,0330.01%
BLB&B Advisors, LLC 75,000$45,7940.00%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders